All In Biotech

Drug Trial Radar · NCT06765109

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

A Phase 3 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 Compared to Alectinib in First-Line Treatment of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (ALKAZAR)

Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

450

Planned (sponsor's estimate)

Start

Jul 17, 2025

Primary completion

Dec 2029

Study completion Dec 2029

Sponsor

Lead sponsor
Nuvalent Inc.Industry
Sponsor type
Industry
First posted
Jan 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Multicenter, randomized, controlled, open-label, Phase 3 study designed to demonstrate that neladalkib (NVL-655) is superior to alectinib in prolonging progression-free survival (PFS) in patients with treatment-naïve, Anaplastic Lymphoma Kinase (ALK) positive, advanced Non-Small Cell Lung Cancer (NSCLC).

Conditions

  • Non-small Cell Lung Cancer
  • Anaplastic Lymphoma Kinase-positive

Interventions

  • Neladalkib (NVL-655)Drug

    Oral tablet of Neladalkib (NVL-655)

  • AlectinibDrug

    Oral capsule of alectinib

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free survival (PFS) per blinded independent central review (BICR)Time frame: Up to 5 years after first patient dosed

Locations

159 sites in 29 countries. Site status is shown where the registry gives one.

  • Palo Verde Hematology Oncology

    Glendale, Arizona · Recruiting

  • Hoag Hospital Newport Beach

    Newport Beach, California · Recruiting

  • University of California, Irvine Health

    Orange, California · Recruiting

  • Rocky Mountain Cancer Centers

    Boulder, Colorado · Recruiting

  • Sylvester Comprehensive Cancer Center Miami

    Miami, Florida · Recruiting

  • AdventHealth Cancer Institute

    Orlando, Florida · Recruiting

  • H Lee Moffitt Cancer Center and Research Institute

    Tampa, Florida · Recruiting

  • Winship Cancer Institute of Emory University

    Atlanta, Georgia · Recruiting

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • Barbara Ann Karmanos Cancer Institute

    Detroit, Michigan · Withdrawn

  • Washington University Center for Advanced Medicine

    St Louis, Missouri · Recruiting

  • NYU Langone's Perlmutter Cancer Center

    New York, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • Optum Medical Care, PC

    Westbury, New York · Recruiting

  • Carolinas Medical Center

    Charlotte, North Carolina · Recruiting

  • Duke Cancer Center

    Durham, North Carolina · Recruiting

  • University of Cincinnati Cancer Center

    Cincinnati, Ohio · Recruiting

  • The Ohio State University

    Columbus, Ohio · Recruiting

  • Alliance Cancer Specialists

    Sellersville, Pennsylvania · Recruiting

  • SCRI Oncology Partners

    Nashville, Tennessee · Recruiting

  • Virginia Cancer Specialists

    Fairfax, Virginia · Recruiting

  • University of Washington - Fred Hutchinson Cancer Center

    Seattle, Washington · Recruiting

  • Compass Oncology

    Vancouver, Washington · Recruiting

  • Sanatorio Allende

    Córdoba, Argentina · Recruiting

  • Centro Médico Privado CEMIC

    Córdoba, Argentina · Recruiting

  • Sanatorio Parque S.A.

    Rosario, Santa Fe Province, Argentina · Recruiting

  • Peter MacCallum Cancer Centre

    Melbourne, Australia · Recruiting

  • Westmead Hospital

    Westmead, New South Wales, Australia · Recruiting

  • Austin Health

    Heidelberg, Victoria, Australia · Recruiting

  • Wiener Gesundheitsverbund

    Vienna, Austria · Recruiting

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium · Recruiting

  • Antwerp University Hospital

    Edegem, Belgium · Recruiting

  • UZ Leuven

    Leuven, Belgium · Recruiting

  • Fundação Pio XII

    Barretos, Brazil · Recruiting

  • Santa Casa de Misericordia de Belo Horizonte

    Belo Horizonte, Brazil · Recruiting

  • Irmandade Da Santa Casa de Misericordia de Porto Alegre

    Porto Alegre, Brazil · Recruiting

  • Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul

    Porto Alegre, Brazil · Recruiting

  • Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base

    São José do Rio Preto, Brazil · Recruiting

  • Instituto do Cancer do Estado de São Paulo ICESP

    São Paulo, Brazil · Recruiting

  • A.C.Camargo Cancer Center

    São Paulo, Brazil · Recruiting

Showing 40 of 159 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.